Michael D Kim
Overview
Explore the profile of Michael D Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
3623
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim M, Chung S, Baumlin N, Qian J, Montgomery R, Sabater J, et al.
Sci Rep
. 2024 Jan;
14(1):1942.
PMID: 38253598
Despite concerns over their safety, e-cigarettes (e-cigs) remain a popular tobacco product. Although nicotine and flavors found in e-cig liquids (e-liquids) can cause harm in the airways, whether the delivery...
2.
Kim M, Chung S, Baumlin N, Sun L, Silswal N, Dennis J, et al.
Am J Physiol Lung Cell Mol Physiol
. 2023 Feb;
324(4):L468-L479.
PMID: 36809074
Propylene glycol (PG) is a common delivery vehicle for nicotine and flavorings in e-cigarette (e-cig) liquids and is largely considered safe for ingestion. However, little is known about its effects...
3.
Baumlin N, Silswal N, Dennis J, Niloy A, Kim M, Salathe M
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675209
Flavorings enhance the palatability of e-cigarettes (e-cigs), with menthol remaining a popular choice among e-cig users. Menthol flavor remains one of the only flavors approved by the United States FDA...
4.
Kim M, Chung S, Dennis J, Yoshida M, Aguiar C, Aller S, et al.
Front Pharmacol
. 2022 Oct;
13:1012723.
PMID: 36225570
Vegetable glycerin (VG) and propylene glycol (PG) serve as delivery vehicles for nicotine and flavorings in most e-cigarette (e-cig) liquids. Here, we investigated whether VG e-cig aerosols, in the absence...
5.
Bengtson C, Kim M, Salathe M
J Cyst Fibros
. 2022 Aug;
21(6):901-903.
PMID: 36028422
No abstract available.
6.
Kim M, Baumlin N, Guerrero-Cignarella A, Schmid A, Aguiar C, Mohiuddin M, et al.
ERJ Open Res
. 2022 Jun;
8(2).
PMID: 35747232
. https://bit.ly/3FyqIt9.
7.
Kim M, Bengtson C, Yoshida M, Niloy A, Dennis J, Baumlin N, et al.
J Clin Invest
. 2022 Apr;
132(11).
PMID: 35446787
Highly effective modulator therapies dramatically improve the prognosis for those with cystic fibrosis (CF). The triple combination of elexacaftor, tezacaftor, and ivacaftor (ETI) benefits many, but not all, of those...
8.
Garcia-Arcos I, Park S, Mai M, Alvarez-Buve R, Chow L, Cai H, et al.
J Lipid Res
. 2022 Feb;
63(4):100185.
PMID: 35202607
The LDL receptor-related protein 1 (LRP1) partakes in metabolic and signaling events regulated in a tissue-specific manner. The function of LRP1 in airways has not been studied. We aimed to...
9.
Bengtson C, He J, Kim M, Salathe M
Am J Respir Crit Care Med
. 2021 Sep;
204(11):1343-1345.
PMID: 34469275
No abstract available.
10.
Zou W, Xiong M, Hao S, Zhang E, Baumlin N, Kim M, et al.
mBio
. 2021 May;
12(3).
PMID: 33975939
The spike (S) polypeptide of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) consists of the S1 and S2 subunits and is processed by cellular proteases at the S1/S2 boundary that...